002382 蓝帆医疗
已收盘 07-09 15:00:00
资讯
新帖
简况
蓝帆医疗(002382.SZ)子公司新一代可回收经导管主动脉瓣置换术输送系统获CE证书
智通财经 · 06-27
蓝帆医疗(002382.SZ)子公司新一代可回收经导管主动脉瓣置换术输送系统获CE证书
蓝帆医疗(002382)6月20日股东户数7.84万户，较上期减少3.01%
证券之星 · 06-25
蓝帆医疗(002382)6月20日股东户数7.84万户，较上期减少3.01%
蓝帆医疗：只要在股东大会股权登记日持有公司股份均可以参加股东大会
证券之星 · 05-30
蓝帆医疗：只要在股东大会股权登记日持有公司股份均可以参加股东大会
蓝帆医疗预计触发可转债转股价格向下修正条件
中访网财观 · 05-21
蓝帆医疗预计触发可转债转股价格向下修正条件
蓝帆医疗收盘上涨1.14%，最新市净率0.66，总市值53.48亿元
金融界 · 05-19
蓝帆医疗收盘上涨1.14%，最新市净率0.66，总市值53.48亿元
【蓝帆医疗：蓝帆集团持股比例降至10.96%】蓝帆医疗公告，信息披露义务人蓝帆集团因山东朗晖向蓝帆投资增资，导致蓝帆集团持有蓝帆投资的股权比例从98%被稀释到47.0013%，使蓝帆医疗的间接控股股东由蓝帆集团变更为山东朗晖。蓝帆集团持有蓝帆医疗的股份比例从23.31%减少至10.96%。此次权益变动不涉及股份买卖，蓝帆集团在未来12个月内暂无增持或减持计划。
金融界 · 05-16
【蓝帆医疗：蓝帆集团持股比例降至10.96%】蓝帆医疗公告，信息披露义务人蓝帆集团因山东朗晖向蓝帆投资增资，导致蓝帆集团持有蓝帆投资的股权比例从98%被稀释到47.0013%，使蓝帆医疗的间接控股股东由蓝帆集团变更为山东朗晖。蓝帆集团持有蓝帆医疗的股份比例从23.31%减少至10.96%。此次权益变动不涉及股份买卖，蓝帆集团在未来12个月内暂无增持或减持计划。
蓝帆医疗（002382）2025年一季报简析：营收净利润同比双双增长，商誉占比较高
证券之星 · 04-29
蓝帆医疗（002382）2025年一季报简析：营收净利润同比双双增长，商誉占比较高
异动快报：蓝帆医疗（002382）4月29日9点34分触及涨停板
证券之星 · 04-29
异动快报：蓝帆医疗（002382）4月29日9点34分触及涨停板
图解蓝帆医疗年报：第四季度单季净利润同比减6.14%
证券之星 · 04-29
图解蓝帆医疗年报：第四季度单季净利润同比减6.14%
图解蓝帆医疗一季报：第一季度单季净利润同比增177.86%
证券之星 · 04-28
图解蓝帆医疗一季报：第一季度单季净利润同比增177.86%
蓝帆医疗：2024年公司健康防护事业部的手套产品综合销量较去年同期增长近29%
证券之星 · 04-15
蓝帆医疗：2024年公司健康防护事业部的手套产品综合销量较去年同期增长近29%
蓝帆医疗(002382.SZ)拟非公开发行不超5亿元公司债券
智通财经 · 03-10
蓝帆医疗(002382.SZ)拟非公开发行不超5亿元公司债券
蓝帆医疗最新公告：拟非公开发行不超过5亿元公司债券
证券之星 · 03-10
蓝帆医疗最新公告：拟非公开发行不超过5亿元公司债券
蓝帆医疗02月28日涨停分析
同花顺AI资讯社 · 02-28
蓝帆医疗02月28日涨停分析
2月28日蓝帆医疗涨停分析：丁辛醇，流感，医疗器械概念热股
证券之星 · 02-28
2月28日蓝帆医疗涨停分析：丁辛醇，流感，医疗器械概念热股
异动快报：蓝帆医疗（002382）2月28日10点1分触及涨停板
证券之星 · 02-28
异动快报：蓝帆医疗（002382）2月28日10点1分触及涨停板
蓝帆医疗(002382.SZ)发预亏，预计2024年度净亏损3.7亿元至4.7亿元
智通财经 · 01-24
蓝帆医疗(002382.SZ)发预亏，预计2024年度净亏损3.7亿元至4.7亿元
蓝帆医疗（002382）1月9日主力资金净买入56.32万元
证券之星 · 01-10
蓝帆医疗（002382）1月9日主力资金净买入56.32万元
蓝帆医疗收盘下跌0.38%，最新市净率0.61
金融界 · 2024-12-26
蓝帆医疗收盘下跌0.38%，最新市净率0.61
加载更多
公司概况
公司名称：
蓝帆医疗股份有限公司
所属行业：
专用设备制造业
上市日期：
2010-04-02
主营业务：
蓝帆医疗股份有限公司的主营业务是心脑血管业务、健康防护业务及护理业务。公司的主要产品是心脑血管产品、健康防护产品、急救救护产品。公司拥有自主研发、全球独家专利药物BA9™，多年来累计收获了超3亿美元的专利许可收入；原研了全球第一款无聚合物药物涂层冠脉支架BioFreedom®、国内首款莫司类药物涂层球囊BA9™药球、用于心血管全钙化病变治疗的SoniCrackerTM冠脉血管内冲击波导管及其他多款支架和球囊产品。公司坚持推出新产品、以重磅产品带动其他产品进院、以新质生产力推动业务快速增长。
发行价格：
35.00
{"stockData":{"symbol":"002382","market":"SZ","secType":"STK","nameCN":"蓝帆医疗","latestPrice":6.21,"timestamp":1752044628000,"preClose":6.01,"halted":0,"volume":30820233,"delay":0,"changeRate":0.0333,"floatShares":1000000000,"shares":1007000000,"eps":-0.2678,"marketStatus":"已收盘","change":0.2,"latestTime":"07-09 15:00:00","open":6,"high":6.31,"low":5.96,"amount":191000000,"amplitude":0.0582,"askPrice":6.21,"askSize":1795,"bidPrice":6.2,"bidSize":458,"shortable":0,"etf":0,"ttmEps":-0.2678,"tradingStatus":0,"nextMarketStatus":{"tag":"开盘","tradingStatus":2,"beginTime":1752111000000},"marketStatusCode":5,"adr":0,"adjPreClose":6.01,"symbolType":"stock","openAndCloseTimeList":[[1752024600000,1752031800000],[1752037200000,1752044400000]],"highLimit":6.61,"lowLimit":5.41,"ibTradeSell":false,"ibTradeBuySell":true,"totalEquity":1007129466,"isCdr":false,"pbRate":0.75,"roa":"--","roe":"0.94%","epsLYR":-0.44,"committee":-0.288684,"marketValue":6254000000,"turnoverRate":0.0308,"status":0,"floatMarketCap":6208000000},"requestUrl":"/m/hq/s/002382","defaultTab":"news","newsList":[{"id":"2546997790","title":"蓝帆医疗(002382.SZ)子公司新一代可回收经导管主动脉瓣置换术输送系统获CE证书","url":"https://stock-news.laohu8.com/highlight/detail?id=2546997790","media":"智通财经","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2546997790?lang=zh_cn&edition=full","pubTime":"2025-06-27 16:29","pubTimestamp":1751012949,"startTime":"0","endTime":"0","summary":"智通财经APP讯，蓝帆医疗(002382.SZ)公告，公司心脑血管事业部旗下子公司德国NVTGmbH研发的新一代可回收经导管主动脉瓣置换术(TAVR)输送系统IMPERIA™(简称“IMPERIA™输送系统”)获得欧盟CE认证，该输送系统用于搭配公司旗下已上市的ALLEGRA™系列主动脉瓣膜使用以实现可回收功能。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1310801.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BK0077","BK4585","BK0251","BK4588","BK4109","002382","CE","BK0114"],"gpt_icon":0},{"id":"2546729770","title":"蓝帆医疗(002382)6月20日股东户数7.84万户，较上期减少3.01%","url":"https://stock-news.laohu8.com/highlight/detail?id=2546729770","media":"证券之星","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2546729770?lang=zh_cn&edition=full","pubTime":"2025-06-25 17:10","pubTimestamp":1750842621,"startTime":"0","endTime":"0","summary":"证券之星消息，近日蓝帆医疗披露，截至2025年6月20日公司股东户数为7.84万户，较4月18日减少2434.0户，减幅为3.01%。在医疗器械行业个股中，蓝帆医疗股东户数高于行业平均水平，截至6月20日，医疗器械行业平均股东户数为2.17万户。从股价来看，2025年4月18日至2025年6月20日，蓝帆医疗区间涨幅为17.07%，在此期间股东户数减少2434.0户，减幅为3.01%。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025062500027488.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0077","BK0114","002382","BK0251"],"gpt_icon":0},{"id":"2539274692","title":"蓝帆医疗：只要在股东大会股权登记日持有公司股份均可以参加股东大会","url":"https://stock-news.laohu8.com/highlight/detail?id=2539274692","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2539274692?lang=zh_cn&edition=full","pubTime":"2025-05-30 20:51","pubTimestamp":1748609492,"startTime":"0","endTime":"0","summary":"证券之星消息，蓝帆医疗05月29日在投资者关系平台上答复投资者关心的问题。投资者提问：我已经持股蓝帆医疗有4年，也亏了150万，就想问问，贵公司的股东大会，应该持股多少才有资格参与，我想到自己投资的企业去看看应该如何联系？","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025053000040277.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0251","BK0077","BK0114","002382"],"gpt_icon":0},{"id":"2537266958","title":"蓝帆医疗预计触发可转债转股价格向下修正条件","url":"https://stock-news.laohu8.com/highlight/detail?id=2537266958","media":"中访网财观","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2537266958?lang=zh_cn&edition=full","pubTime":"2025-05-22 01:01","pubTimestamp":1747846860,"startTime":"0","endTime":"0","summary":"来源：中访网财观中访网数据 蓝帆医疗股份有限公司发布公告称，截至2025年5月21日，公司股票已有10个交易日的收盘价低于当期转股价格12.50元/股的85%，预计触发“蓝帆转债”转股价格向下修正条件。若触发条件，蓝帆医疗将于触发当日召开董事会决定是否修正转股价格，并及时履行信息披露义务。“蓝帆转债”于2020年5月28日发行，发行总额31.44亿元，当前转股价格为12.50元/股。","market":"other","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.sina.com.cn/cj/2025-05-22/doc-inexkerv0291323.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"sina","symbols":["BK0251","BK0077","002382","BK0114"],"gpt_icon":0},{"id":"2536505450","title":"蓝帆医疗收盘上涨1.14%，最新市净率0.66，总市值53.48亿元","url":"https://stock-news.laohu8.com/highlight/detail?id=2536505450","media":"金融界","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2536505450?lang=zh_cn&edition=full","pubTime":"2025-05-19 16:41","pubTimestamp":1747644090,"startTime":"0","endTime":"0","summary":"5月19日，蓝帆医疗今日收盘5.31元，上涨1.14%，最新市净率0.66，创47天以来新低，总市值53.48亿元。股东方面，截至2025年4月18日，蓝帆医疗股东户数80811户，较上次减少95户，户均持股市值35.28万元，户均持股数量2.76万股。蓝帆医疗股份有限公司主要业务是心脑血管业务、健康防护业务及护理业务。蓝帆医疗是全球PVC健康防护手套行业的龙头企业，PVC健康防护手套年产销量及市场占有率均为全球第一。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.jrj.com.cn/2025/05/19164150495830.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"jinrongjie_stock","symbols":["BK0077","002382","BK0114","BK0251"],"gpt_icon":0},{"id":"2535166396","title":"【蓝帆医疗：蓝帆集团持股比例降至10.96%】蓝帆医疗公告，信息披露义务人蓝帆集团因山东朗晖向蓝帆投资增资，导致蓝帆集团持有蓝帆投资的股权比例从98%被稀释到47.0013%，使蓝帆医疗的间接控股股东由蓝帆集团变更为山东朗晖。蓝帆集团持有蓝帆医疗的股份比例从23.31%减少至10.96%。此次权益变动不涉及股份买卖，蓝帆集团在未来12个月内暂无增持或减持计划。","url":"https://stock-news.laohu8.com/highlight/detail?id=2535166396","media":"金融界","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2535166396?lang=zh_cn&edition=full","pubTime":"2025-05-16 19:27","pubTimestamp":1747394843,"startTime":"0","endTime":"0","summary":"蓝帆医疗公告，信息披露义务人蓝帆集团因山东朗晖向蓝帆投资增资，导致蓝帆集团持有蓝帆投资的股权比例从98%被稀释到47.0013%，使蓝帆医疗的间接控股股东由蓝帆集团变更为山东朗晖。蓝帆集团持有蓝帆医疗的股份比例从23.31%减少至10.96%。此次权益变动不涉及股份买卖，蓝帆集团在未来12个月内暂无增持或减持计划。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://24h.jrj.com.cn/2025/05/16192750458795.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"jinrongjie_stock","symbols":["BK0114","BK0077","002382","BK0251"],"gpt_icon":0},{"id":"2531714601","title":"蓝帆医疗（002382）2025年一季报简析：营收净利润同比双双增长，商誉占比较高","url":"https://stock-news.laohu8.com/highlight/detail?id=2531714601","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2531714601?lang=zh_cn&edition=full","pubTime":"2025-04-30 06:55","pubTimestamp":1745967348,"startTime":"0","endTime":"0","summary":"据证券之星公开数据整理，近期蓝帆医疗发布2025年一季报。根据财报显示，蓝帆医疗营收净利润同比双双增长，商誉占比较高。截至本报告期末，公司营业总收入14.78亿元，同比上升1.59%，归母净利润7702.23万元，同比上升177.86%。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025043000008599.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["002382"],"gpt_icon":0},{"id":"2531215624","title":"异动快报：蓝帆医疗（002382）4月29日9点34分触及涨停板","url":"https://stock-news.laohu8.com/highlight/detail?id=2531215624","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2531215624?lang=zh_cn&edition=full","pubTime":"2025-04-29 09:37","pubTimestamp":1745890631,"startTime":"0","endTime":"0","summary":"证券之星4月29日盘中消息，9点34分蓝帆医疗触及涨停板。目前价格4.94，上涨10.02%。其所属行业医疗器械目前下跌。领涨股为易瑞生物。该股为丁辛醇，新冠病毒防治，互联网医疗概念热股，当日丁辛醇概念上涨0.6%。4月28日的资金流向数据方面，主力资金净流入312.54万元，占总成交额9.31%，游资资金净流出5.97万元，占总成交额0.18%，散户资金净流出306.57万元，占总成交额9.13%。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025042900012060.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["002382","BK0251","BK0077","BK0114"],"gpt_icon":0},{"id":"2531292710","title":"图解蓝帆医疗年报：第四季度单季净利润同比减6.14%","url":"https://stock-news.laohu8.com/highlight/detail?id=2531292710","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2531292710?lang=zh_cn&edition=full","pubTime":"2025-04-29 08:35","pubTimestamp":1745886923,"startTime":"0","endTime":"0","summary":"证券之星消息，蓝帆医疗2024年年报显示，公司主营收入62.53亿元，同比上升26.91%；归母净利润-4.46亿元，同比上升21.6%；扣非净利润-4.8亿元，同比上升24.97%；其中2024年第四季度，公司单季度主营收入15.99亿元，同比上升19.07%；单季度归母净利润-2.26亿元，同比下降6.14%；单季度扣非净利润-2.31亿元，同比下降16.7%；负债率41.67%，投资收益-747.44万元，财务费用1.99亿元，毛利率16.48%。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025042900010045.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["002382"],"gpt_icon":0},{"id":"2531926128","title":"图解蓝帆医疗一季报：第一季度单季净利润同比增177.86%","url":"https://stock-news.laohu8.com/highlight/detail?id=2531926128","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2531926128?lang=zh_cn&edition=full","pubTime":"2025-04-29 05:04","pubTimestamp":1745874262,"startTime":"0","endTime":"0","summary":"证券之星消息，蓝帆医疗2025年一季报显示，公司主营收入14.78亿元，同比上升1.59%；归母净利润7702.23万元，同比上升177.86%；扣非净利润-6079.07万元，同比上升51.02%；负债率41.69%，投资收益179.86万元，财务费用4229.47万元，毛利率17.17%。财报数据概要请见下图:以上内容为证券之星据公开信息整理，由AI算法生成（网信算备310104345710301240019号），不构成投资建议。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025042900002430.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["002382"],"gpt_icon":0},{"id":"2527041664","title":"蓝帆医疗：2024年公司健康防护事业部的手套产品综合销量较去年同期增长近29%","url":"https://stock-news.laohu8.com/highlight/detail?id=2527041664","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2527041664?lang=zh_cn&edition=full","pubTime":"2025-04-15 20:48","pubTimestamp":1744721291,"startTime":"0","endTime":"0","summary":"证券之星消息，蓝帆医疗(002382)04月14日在投资者关系平台上答复投资者关心的问题。投资者提问：24年出口份额怎么样？全国排名怎么样？蓝帆医疗回复：您好，2024年公司健康防护事业部的手套产品综合销量较去年同期增长近 29%，综合生产量较去年同期增长近 29%，产销量和市占率均有提升。感谢您的关注。以上内容为证券之星据公开信息整理，由智能算法生成（网信算备310104345710301240019号），不构成投资建议。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025041500034801.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["002382","BK0251","BK0114","BK0077"],"gpt_icon":0},{"id":"2518117772","title":"蓝帆医疗(002382.SZ)拟非公开发行不超5亿元公司债券","url":"https://stock-news.laohu8.com/highlight/detail?id=2518117772","media":"智通财经","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2518117772?lang=zh_cn&edition=full","pubTime":"2025-03-10 17:11","pubTimestamp":1741597883,"startTime":"0","endTime":"0","summary":"智通财经APP讯，蓝帆医疗(002382.SZ)发布公告，为拓宽融资渠道并优化公司债务结构，结合公司实际情况，同意面向专业投资者非公开发行不超过人民币5亿元(含5亿元)公司债券。本次债券募集资金拟用于公司生产经营需要、偿还有息债务、补充流动资金及(或)项目投资、股权投资等符合国家法律法规及政策要求的企业经营活动。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1259801.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BK0251","BK0077","002382","BK0114"],"gpt_icon":0},{"id":"2518214239","title":"蓝帆医疗最新公告：拟非公开发行不超过5亿元公司债券","url":"https://stock-news.laohu8.com/highlight/detail?id=2518214239","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2518214239?lang=zh_cn&edition=full","pubTime":"2025-03-10 17:10","pubTimestamp":1741597827,"startTime":"0","endTime":"0","summary":"蓝帆医疗(002382.SZ)公告称，公司于2025年3月9日召开董事会和监事会，审议通过非公开发行公司债券预案，拟面向专业投资者发行不超过5亿元公司债券，用于生产经营需要、偿还有息债务等。该预案尚需提交股东大会审议并获得深交所无异议函后方可实施。以上内容为证券之星据公开信息整理，由智能算法生成（网信算备310104345710301240019号），不构成投资建议。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025031000022836.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0077","002382","BK0114","BK0251"],"gpt_icon":0},{"id":"2514466493","title":"蓝帆医疗02月28日涨停分析","url":"https://stock-news.laohu8.com/highlight/detail?id=2514466493","media":"同花顺AI资讯社","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2514466493?lang=zh_cn&edition=full","pubTime":"2025-02-28 17:00","pubTimestamp":1740733200,"startTime":"0","endTime":"0","summary":"蓝帆医疗02月28日涨停收盘，股价上涨9.98%，收盘价为5.51元。该股于上午 10:01:57涨停。截止15:00:31打开涨停1次，封住涨停时长3小时25分45秒。蓝帆医疗涨停原因类别为估值提升计划+医疗器械+业绩改善。","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.sina.com.cn/stock/relnews/cn/2025-02-28/doc-inemzpzi5587097.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"sina","symbols":["BK0114","BK0077","002382","BK0251"],"gpt_icon":0},{"id":"2514313548","title":"2月28日蓝帆医疗涨停分析：丁辛醇，流感，医疗器械概念热股","url":"https://stock-news.laohu8.com/highlight/detail?id=2514313548","media":"证券之星","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2514313548?lang=zh_cn&edition=full","pubTime":"2025-02-28 15:12","pubTimestamp":1740726743,"startTime":"0","endTime":"0","summary":"证券之星消息，蓝帆医疗2月28日涨停收盘，收盘价5.51元。该股于10点1分涨停，1次打开涨停，截止收盘封单资金为4327.98万元，占其流通市值0.79%。2月28日的资金流向数据方面，主力资金净流入7438.18万元，占总成交额31.85%，游资资金净流出2370.32万元，占总成交额10.15%，散户资金净流出5067.85万元，占总成交额21.7%。近5日资金流向一览见下表：该股为丁辛醇，流感，医疗器械概念热股，当日丁辛醇概念上涨1.34%。以上内容为证券之星据公开信息整理，由智能算法生成（网信算备310104345710301240019号），不构成投资建议。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025022800021071.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK1222","BK1574","002382","09997","159883","BK1583","BK0251","BK0077","09996","BK0114","BK1100"],"gpt_icon":0},{"id":"2514361755","title":"异动快报：蓝帆医疗（002382）2月28日10点1分触及涨停板","url":"https://stock-news.laohu8.com/highlight/detail?id=2514361755","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2514361755?lang=zh_cn&edition=full","pubTime":"2025-02-28 10:05","pubTimestamp":1740708332,"startTime":"0","endTime":"0","summary":"证券之星2月28日盘中消息，10点1分蓝帆医疗（002382）触及涨停板。目前价格5.51，上涨9.98%。该股为丁辛醇，流感，医疗器械概念热股，当日丁辛醇概念上涨1.34%。2月27日的资金流向数据方面，主力资金净流出613.39万元，占总成交额14.69%，游资资金净流入387.56万元，占总成交额9.28%，散户资金净流入225.84万元，占总成交额5.41%。近5日资金流向一览见下表：蓝帆医疗主要指标及行业内排名如下：以上内容为证券之星据公开信息整理，由智能算法生成（网信算备310104345710301240019号），不构成投资建议。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025022800011269.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0251","002382","BK0077","BK0114"],"gpt_icon":0},{"id":"2505185636","title":"蓝帆医疗(002382.SZ)发预亏，预计2024年度净亏损3.7亿元至4.7亿元","url":"https://stock-news.laohu8.com/highlight/detail?id=2505185636","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2505185636?lang=zh_cn&edition=full","pubTime":"2025-01-24 19:56","pubTimestamp":1737719807,"startTime":"0","endTime":"0","summary":"智通财经APP讯，蓝帆医疗(002382.SZ)发布2024年年度业绩预告，预计全年归母净亏损3.7亿元至4.7亿元。报告期内心脑血管事业部销售收入突破11亿元，同比增长约12%，毛利率进一步提升，延续2021年冠脉支架国家集采以来收入逐年增长、销售费用率及管理费用率逐年降低、经营性亏损逐年明显缩窄的向好态势。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1243755.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BK0251","BK0077","002382","BK0114"],"gpt_icon":0},{"id":"2502008929","title":"蓝帆医疗（002382）1月9日主力资金净买入56.32万元","url":"https://stock-news.laohu8.com/highlight/detail?id=2502008929","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2502008929?lang=zh_cn&edition=full","pubTime":"2025-01-10 09:25","pubTimestamp":1736472353,"startTime":"0","endTime":"0","summary":"证券之星消息，截至2025年1月9日收盘，蓝帆医疗报收于4.87元，下跌1.62%，换手率0.57%，成交量5.71万手，成交额2794.71万元。近5日资金流向一览见下表：蓝帆医疗融资融券信息显示，融资方面，当日融资买入293.89万元，融资偿还128.55万元，融资净买入165.34万元。蓝帆医疗主营业务：心脑血管业务、健康防护业务、应急救护业务、新营销业务。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025011000008299.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0114","BK0077","002382","BK0251"],"gpt_icon":0},{"id":"2494183269","title":"蓝帆医疗收盘下跌0.38%，最新市净率0.61","url":"https://stock-news.laohu8.com/highlight/detail?id=2494183269","media":"金融界","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2494183269?lang=zh_cn&edition=full","pubTime":"2024-12-26 16:53","pubTimestamp":1735203225,"startTime":"0","endTime":"0","summary":"12月26日，蓝帆医疗今日收盘5.2元，下跌0.38%，最新市净率0.61。截至2024年三季报，共有4家机构持仓蓝帆医疗，其中其他4家，合计持股数27823.50万股，持股市值14.80亿元。蓝帆医疗股份有限公司主要业务是心脑血管业务、健康防护业务及护理业务。蓝帆医疗是全球PVC健康防护手套行业的龙头企业，PVC健康防护手套年产销量及市场占有率均为全球第一。最新一期业绩显示，2024年三季报，公司实现营业收入46.54亿元，同比29.85%；净利润-219822842.84元，同比38.19%，销售毛利率17.17%。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.jrj.com.cn/2024/12/26165346845559.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"jinrongjie_stock","symbols":["BK0077","002382","BK0114","BK0251"],"gpt_icon":0}],"profile":{"ret":0,"serverTime":1752065433236,"stockEarnings":[{"period":"1week","weight":0.0452},{"period":"1month","weight":0.1048},{"period":"3month","weight":0.3296},{"period":"6month","weight":0.2341},{"period":"1year","weight":0.4175},{"period":"ytd","weight":0.1715}],"compareEarnings":[{"period":"1week","weight":0.0115},{"period":"1month","weight":0.0331},{"period":"3month","weight":0.0975},{"period":"6month","weight":0.0891},{"period":"1year","weight":0.1968},{"period":"ytd","weight":0.0435}],"compareStock":{"symbol":"000001.SH","name":"上证指数"},"companyName":"蓝帆医疗股份有限公司","boardCode":"AI0035","boardName":"专用设备制造业","stockholders":"78377人(较上一季度减少1.44%)","perCapita":"12754股","listingDate":"2010-04-02","address":"山东省淄博市临淄区稷下街道一诺路48号","registeredCapital":"100712万元","survey":" 蓝帆医疗股份有限公司的主营业务是心脑血管业务、健康防护业务及护理业务。公司的主要产品是心脑血管产品、健康防护产品、急救救护产品。公司拥有自主研发、全球独家专利药物BA9™，多年来累计收获了超3亿美元的专利许可收入；原研了全球第一款无聚合物药物涂层冠脉支架BioFreedom®、国内首款莫司类药物涂层球囊BA9™药球、用于心血管全钙化病变治疗的SoniCrackerTM冠脉血管内冲击波导管及其他多款支架和球囊产品。公司坚持推出新产品、以重磅产品带动其他产品进院、以新质生产力推动业务快速增长。","listedPrice":35},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"deviceId":"web-server-community-laohu8-v3","version":"4.34.3","shortVersion":"4.34.3","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"蓝帆医疗(002382)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供蓝帆医疗(002382)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"蓝帆医疗,002382,蓝帆医疗股票,蓝帆医疗股票老虎,蓝帆医疗股票老虎国际,蓝帆医疗行情,蓝帆医疗股票行情,蓝帆医疗股价,蓝帆医疗股市,蓝帆医疗股票价格,蓝帆医疗股票交易,蓝帆医疗股票购买,蓝帆医疗股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"蓝帆医疗(002382)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供蓝帆医疗(002382)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}